Episurf Medical First Quarter 2025 Earnings: kr0.025 loss per share (vs kr0.077 loss in 1Q 2024)

Episurf Medical (STO:EPIS B) First Quarter 2025 Results

Key Financial Results

• Revenue: kr6.40m (up 107% from 1Q 2024).
• Net loss: kr16.6m (loss narrowed by 19% from 1Q 2024).
• kr0.025 loss per share (improved from kr0.077 loss in 1Q 2024).

Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Episurf Medical Earnings Insights

Looking ahead, revenue is forecast to grow 51% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Medical Equipment industry in Sweden.

Performance of the Swedish Medical Equipment industry.

The company's shares are up 11% from a week ago.

Risk Analysis

You should always think about risks. Case in point, we've spotted 6 warning signs for Episurf Medical you should be aware of, and 3 of them are a bit concerning.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.